English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

PurposeThe purpose of this study was to evaluate the efficiency of transarterial chemoembolization using drug eluting microspheres loaded with irinotecan in the treatment of the colorectal liver metastases after failure of chemotherapy.Patients and methodsThis prospective study was conducted from March 2014 to June 2016. The patients including 16 men and 6 women (mean age, 55 years) with metastatic colorectal carcinoma to the liver underwent transarterial chemoembolization using drug eluting microspheres as a salvage therapy after failure of systemic chemotherapy. Each patient underwent 18F-FDG PET/CT study before the procedure as well as 2 and 4 months after it to assess the response to therapy.ResultsFavorable response was seen in 13 patients (59.1% of patients), progression of the disease occurred in 3 patients (13.6% of patients) while stationary disease was seen in 5 patients (22.7% of patients) and one patient died from brain metastases before the 2 months follow-up.ConclusionTransarterial chemoembolization using drug-eluting microspheres loaded with irinotecan is a safe and effective salvage treatment of liver metastases from colorectal carcinoma not responding to systemic chemotherapy

the egyptian journal of radiology and nuclear medicine /the egyptian journal of radiology and nuclear medicine

Transarterial chemoembolization using drug eluting microspheres in refractory colorectal liver metastases with 18F-FDG PET/CT follow-up to assess therapeutic response